Cognition Therapeutics In...

NASDAQ: CGTX · Real-Time Price · USD
1.54
-0.12 (-7.23%)
At close: Aug 15, 2025, 3:59 PM
1.57
1.62%
After-hours: Aug 15, 2025, 07:56 PM EDT

Cognition Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 250K n/a n/a n/a 372K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
61K 45K 71K 70K 67K 58K 66K 65K 61K 60K 60K 60K 59K 56K 23K 23K 24K 23K
Gross Profit
-61K -45K -71K -70K -67K -58K 306K -65K -61K -60K -60K -60K -59K -56K -23K -23K -24K -23K
Operating Income
-13.98M -13.78M -10.72M -14.46M -14.68M -14.1M -15.19M -14.74M -11.82M -8.97M -9.3M -12.63M -12.21M -9.41M -11.81M -5.22M -5.98M -5.58M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-6.73M -8.48M -7.84M -9.94M -7.04M -9.15M -8.14M -6.75M -4.73M -6.17M -5.18M -6.63M -5.88M -3.71M -7.34M -3.11M -1.49M 223K
Net Income
-6.73M -8.48M -7.84M -9.94M -7.04M -9.15M -8.14M -6.75M -4.73M -3.38M 10.97M -625K -5.75M -3.84M -7.34M -3.11M -1.49M 223K
Selling & General & Admin
2.5M 2.99M 2.57M 3.07M 3.1M 3.49M 3.52M 3.08M 3.32M 3.54M 2.86M 4.36M 3.12M 2.9M 6.24M 1.55M 1.09M 1.15M
Research & Development
11.48M 10.79M 8.15M 11.39M 11.58M 10.55M 11.6M 11.67M 8.5M 5.43M 6.44M 8.27M 9.1M 6.52M 5.57M 3.67M 4.89M 4.43M
Other Expenses
n/a n/a -71K n/a n/a n/a n/a n/a 172K -3.43M -3.98M -5.95M -42K -5.9M -604K -924K -941K 145K
Operating Expenses
13.98M 13.78M 10.65M 14.46M 14.68M 14.04M 15.12M 14.74M 4.89M 5.55M 5.32M 6.68M 5.83M 3.51M 6.74M 2.19M 1.34M 891K
Interest Expense
3K -5K 5K 3K 7K 10K 9K 2K 6K 10K 10K 2K 7K 9K n/a n/a 357K 537K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -58K -66K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
13.98M 13.78M 10.72M 14.46M 14.68M 14.1M 15.19M 14.74M 4.89M 5.55M 5.32M 6.68M 5.83M 3.51M 6.74M 2.19M 1.34M 891K
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.79M -16.15M -6M -125K 125K n/a n/a n/a n/a
Shares Outstanding (Basic)
63.69M 61.83M 46.43M 40.42M 40.06M 33.74M 30.78M 30.37M 29.61M 29.09M 28.99M 23.02M 22.6M 22.43M 20.95M 20.95M 20.95M 21.37M
Shares Outstanding (Diluted)
63.69M 61.83M 46.43M 40.42M 40.06M 33.74M 30.78M 30.37M 29.61M 29.09M 28.99M 23.02M 22.6M 22.43M 20.95M 20.95M 20.95M 21.37M
EPS (Basic)
-0.11 -0.14 -0.17 -0.25 -0.18 -0.27 -0.26 -0.22 -0.16 -0.12 0.38 -0.03 -0.25 -0.17 -0.35 -0.15 -0.07 0.01
EPS (Diluted)
-0.11 -0.14 -0.17 -0.25 -0.18 -0.27 -0.26 -0.22 -0.16 -0.12 0.38 -0.03 -0.25 -0.17 -0.35 -0.15 -0.07 0.01
EBITDA
-13.98M -13.78M -7.77M -9.86M -6.97M -9.08M -8.07M -6.68M -4.66M -6.1M -5.11M -6.56M -5.81M -3.65M -7.32M -3.09M -1.11M 783K
EBIT
-6.73M -8.47M -7.84M -9.93M -7.03M -9.14M -8.13M -6.75M -4.72M -6.16M -5.17M -6.62M -5.87M -3.7M -7.34M -3.11M -1.13M 760K
Depreciation & Amortization
n/a 45K 71K 70K 67K 58K 66K 65K 61K 60K 60K 60K 59K 56K 23K 23K 24K 23K